The Valley Desk

NCT06046820 · Interventional trial

The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency

Overall registry status Terminated

Phase 3

Conditions Autosomal Recessive Hypophosphatemic Rickets, Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency, Generalized Arterial Calcification of Infancy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov